Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Minoxidil decreases LH expression, while hydralazine has mixed effects on prolyl and lysyl hydroxylase activities.

PRP shows promise for treating hair loss but needs standardized methods to confirm its effectiveness.

The treatment improved hair health in women with androgenetic alopecia.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that skin stem cells are important for hair growth and wound healing, and could be used in regenerative medicine.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.